{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:04:43Z","timestamp":1794405883647,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Discovery Today: Disease Models"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ddmod.2007.10.003","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T08:25:38Z","timestamp":1196497538000},"page":"17-24","source":"Crossref","is-referenced-by-count":42,"title":["Mouse models of lipodystrophy: Key reagents for the understanding of the metabolic syndrome"],"prefix":"10.1016","volume":"4","author":[{"given":"Ingrid Wernstedt","family":"Asterholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Halberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ddmod.2007.10.003_bib1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1194\/jlr.R700004-JLR200","article-title":"Thematic review series: adipocyte biology. Lipodystrophies: windows on adipose biology and metabolism","volume":"48","author":"Hegele","year":"2007","journal-title":"J. Lipid Res."},{"issue":"Suppl. 4","key":"10.1016\/j.ddmod.2007.10.003_bib2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S1098-3597(06)80039-6","article-title":"Adipose tissue dysfunction in obesity and lipodystrophy","volume":"8","author":"Garg","year":"2006","journal-title":"Clin. Cornerstone"},{"key":"10.1016\/j.ddmod.2007.10.003_bib3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy","volume":"92","author":"Ebihara","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ddmod.2007.10.003_bib4","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy","volume":"54","author":"Javor","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ddmod.2007.10.003_bib5","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy","volume":"12","author":"Shimomura","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.ddmod.2007.10.003_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI200419511","article-title":"Site and mechanism of leptin action in a rodent form of congenital lipodystrophy","volume":"113","author":"Asilmaz","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ddmod.2007.10.003_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ddmod.2007.10.003_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1172\/JCI28859","article-title":"Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality","volume":"117","author":"Duan","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ddmod.2007.10.003_bib9","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ddmod.2007.10.003_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI200317223","article-title":"Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes","volume":"111","author":"Matsusue","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ddmod.2007.10.003_bib11","doi-asserted-by":"crossref","first-page":"15712","DOI":"10.1073\/pnas.2536828100","article-title":"Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle","volume":"100","author":"He","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ddmod.2007.10.003_bib12","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.0306743102","article-title":"Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance","volume":"102","author":"Jones","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ddmod.2007.10.003_bib13","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1073\/pnas.0403652101","article-title":"Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ddmod.2007.10.003_bib14","doi-asserted-by":"crossref","first-page":"14457","DOI":"10.1073\/pnas.2336090100","article-title":"Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice","volume":"100","author":"Koutnikova","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ddmod.2007.10.003_bib15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ddmod.2007.10.003_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1172\/JCI200420964","article-title":"Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma","volume":"114","author":"Tsai","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ddmod.2007.10.003_bib17","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/db06-0389","article-title":"Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice","volume":"55","author":"Gray","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ddmod.2007.10.003_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/83685","article-title":"Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin","volume":"27","author":"Peterfy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ddmod.2007.10.003_bib19","doi-asserted-by":"crossref","first-page":"29558","DOI":"10.1074\/jbc.M403506200","article-title":"Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro","volume":"279","author":"Phan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ddmod.2007.10.003_bib20","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-2275(20)32011-3","article-title":"Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene","volume":"41","author":"Reue","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ddmod.2007.10.003_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmet.2004.12.002","article-title":"Lipin, a lipodystrophy and obesity gene","volume":"1","author":"Phan","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.ddmod.2007.10.003_bib22","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","article-title":"Life without white fat: a transgenic mouse","volume":"12","author":"Moitra","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.ddmod.2007.10.003_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.HYP.0000255576.16089.b9","article-title":"Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function","volume":"49","author":"Takemori","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ddmod.2007.10.003_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","article-title":"Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice","volume":"105","author":"Gavrilova","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ddmod.2007.10.003_bib25","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2337\/diabetes.51.9.2727","article-title":"Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy","volume":"51","author":"Colombo","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ddmod.2007.10.003_bib26","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1101\/gad.1034802","article-title":"Lipoatrophic diabetes in Irs1(\u2212\/\u2212)\/Irs3(\u2212\/\u2212) double knockout mice","volume":"16","author":"Laustsen","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.ddmod.2007.10.003_bib27","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1101\/gad.7.7b.1318","article-title":"Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity","volume":"7","author":"Ross","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.ddmod.2007.10.003_bib28","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1172\/JCI119839","article-title":"Troglitazone action is independent of adipose tissue","volume":"100","author":"Burant","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ddmod.2007.10.003_bib29","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/diabetes.52.6.1340","article-title":"Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2","volume":"52","author":"El-Haschimi","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ddmod.2007.10.003_bib30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm1262","article-title":"Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy","volume":"11","author":"Pajvani","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ddmod.2007.10.003_bib31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ddmod.2007.10.003_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/en.2003-1140","article-title":"Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice","volume":"145","author":"Xu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ddmod.2007.10.003_bib33","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/AAC.00625-06","article-title":"Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice","volume":"50","author":"Prot","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ddmod.2007.10.003_bib34","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00126334-200308150-00003","article-title":"Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice","volume":"33","author":"Riddle","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ddmod.2007.10.003_bib35","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1074\/jbc.M104557200","article-title":"HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus","volume":"276","author":"Riddle","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ddmod.2007.10.003_bib36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.51.4.937","article-title":"Indinavir induces acute and reversible peripheral insulin resistance in rats","volume":"51","author":"Hruz","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ddmod.2007.10.003_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ddmod.2007.10.003_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/341489","article-title":"Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy","volume":"35","author":"Dube","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ddmod.2007.10.003_bib39","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"J. Biol. Chem."}],"container-title":["Drug Discovery Today: Disease Models"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1740675707000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1740675707000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T16:49:23Z","timestamp":1630255763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1740675707000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1740675707000242"],"URL":"https:\/\/doi.org\/10.1016\/j.ddmod.2007.10.003","relation":{},"ISSN":["1740-6757"],"issn-type":[{"value":"1740-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}